The relationship between maternal serum prenatal screening combined with epidemiological study and early onset preeclampsia

Archives of Gynecology and Obstetrics

Volumn 289, Issue 4, 2014, Pages 749-753

  Yu, Hong ^a   Shen, Yan Ting ^a   Li, Hai Ling ^a   Yan, Yun ^a   Ren, Mu Lan ^a   Wang, Bei ^a  

^a SOUTHEAST UNIVERSITY   (China)

Author keywords

AFP; hCG; Preeclampsia; Prenatal screening

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GESTATIONAL AGE; GONADOTROPIN BLOOD LEVEL; HUMAN; INTERVIEW; MATERNAL SERUM SCREENING TEST; PREDICTIVE VALUE; PREECLAMPSIA; PRENATAL SCREENING; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK FACTOR; SECOND TRIMESTER PREGNANCY; SENSITIVITY AND SPECIFICITY;

ADULT; ALPHA-FETOPROTEINS; BODY MASS INDEX; CASE-CONTROL STUDIES; CHORIONIC GONADOTROPIN; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 13; DIABETES MELLITUS; DOWN SYNDROME; EARLY DIAGNOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYPERTENSION; LOGISTIC MODELS; NEPHRITIS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TRISOMY;

EID: 84899021444     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-013-3039-x     Document Type: Article

References (12)

1. Hahn S, Rusterholz C, Hosli I, Lapaire O (2011) Cell-free nucleic acids as potential markers for preeclampsia. Placenta 32(Suppl):S17-S20
2. Sibai BM, Barton JR (2007) Expectant management of severe preeclampsia remote from term: patient selection, treatment, and delivery indications. Am J Obstet Gynecol 196(6):514 e511-519
3. Morris RK, Cnossen JS, Langejans M, Robson SC, Kleijnen J et al (2008) Serum screening with Down's syndrome markers to predict pre-eclampsia and small for gestational age: systematic review and meta-analysis. BMC Pregnancy Childbirth 8:33
4. Di Lorenzo G, Ceccarello M, Cecotti V, Ronfani L, Monasta L et al (2012) First trimester maternal serum PIGF, free b-hCG, PAPP-A, PP-13, uterine artery Doppler and maternal history for the prediction of preeclampsia. Placenta 33:495-501
5. Feng YJ, Shen K (2005) Obstetrics and gynecology. People's Health Publishing House, Beijing, pp 74-84
6. Yu H, Wei W, Shen Y (2010) Logistic regression analysis of risk factors on preeclampsia. J Pract Obstet Gynecol 26(4):273-275
7. Jin HK, Antonio F, Ji HP (2008) Down syndrome biochemical markers and screening for preeclampsia at first and second trimester: correlation with the week of onset and the severity. Prenat Diagn 28:704-709
8. Ahn H, Park J, Gilman-Sachs A, Kwak-Kim J (2011) Immunologic characteristics of preeclampsia, a comprehensive review. Am J Reprod Immunol 65:377-394
9. Servitje EL, Lopez NG, Olson DM (2010) An immunological insight into the origins of preeclampsia. Hum Reprod Update 16(5):510-524
10. Uzan J, Carbonnel M, Piconne O, Asmar R, Ayoubi JM (2011) Pre-eclampsia: pathophysiology, diagnosis, and management. Vasc Health Risk Manag 7:467-474
11. Chen JZ, Sheehan PM, Brennecke SP, Keogh RJ (2012) Vessel remodelling, pregnancy hormones and extravillous trophoblast function. Mol Cell Endocrinol 349:138-144
12. Lambert-Messerlian GM, Silver HM, Petraglia F, Luisi S, Pezzani I et al (2000) Second-trimester levels of maternal serum human chorionic gonadotropin and inhibin a as predictors of preeclampsia in the third trimester of pregnancy. J Soc Gynecol Invest 7(2):170-174 (Pubitemid 30349162)